Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder

Aldridge, A., Kroutil, L., Cowell, A., Reeves, D., & Van Brunt, D. (2011). Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder. PharmacoEconomics, 29(7)(1170-7690), 621 - 635.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

METHODS REPORT

Improving text classification with Boolean retrieval for rare categories
Article

Use of a web-based portal to return normal individual research results in Early Check
Article

Personal exposure to PM2.5 in different microenvironments and activities for retired adults in two megacities, China
Article

Estimating global artisanal fishing fleet responses in an era of rapid climate and economic change